Reliance Pharma Fund


NAV : 158.5526
(+0.417arrow_upward)
AUM : ₹2,690 Cr.


Fund Returns

1 Month3 Months6 Months1 Year2 Years3 Years5 years
27.27%3.3%-14.16%12.56%5.73%5.27%12.58%



Fund Details

An open ended equity scheme investing in pharma sector
NAV158.5526
Launch Date-
Min (1st time)₹5,000
Min (later on)₹1,000
Min SIP-
Expense Ratio0.0%
Exit Load : Entyr Load Nil Exit Load 1% if redeemed or switched out on or before completion of 1 year from the date of allotment of units.


Direct Advantage

Investment of Rs.1,00,000 becomes
With JamaWith BrokerBack2Pocket
After 1 year₹1,12,555₹1,11,577₹979
After 3 years₹1,16,648₹1,13,571₹3,077
After 20 years₹2,79,154₹2,33,582₹45,572

Investment Calculators



SIP Calculator

Per Month

500


Duration (in years)

25

After Years


Direct(Jama)

Broker(Regular)

Direct Savings :


START SIP    



Lumpsum Calculator

One Time

500


Duration (in years)

25

After Years


Direct(Jama)

Broker(Regular)

Direct Savings :


INVEST NOW

Returns assumed : 5.27% Past 3 yr Data

NAV History



Expense Ratio Trends





Fund Objective:
The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses. The fund invests across market capitalization within the sector. It may suit investment horizon of around 2-3 years.
Fund Manager:
Sailesh Raj Bhan















Jamā जमा જમા జమ জমে ജമാ ಜಮ ଜମା ஜமா is a product by Simply Grow Technologies Pvt. Ltd.

Example logo image
Example logo image

Startp India

Jama is a Personal Finance App: Online Financial Planning Tool, Direct Mutual Funds app and more.

Get your financial planning done by the best financial advisors and financial planners.

Investments are advised by a dedicated SEBI Registered Investment Advisor. Mutual Fund investments are subject to market risks. Please read scheme information documents carefully while investing.

Choose your advisor wisely - do not fall for free platforms, or hidden commissions.